# Diagnosis Value of SEMA4C in Breast Cancer

> **NCT03662633** · — · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 2300 (estimated)

## Conditions studied

- Breast Neoplasm Female

## Interventions

- **DIAGNOSTIC_TEST:** Breast cancer group
- **DIAGNOSTIC_TEST:** Benign breast tumor group

## Key facts

- **NCT ID:** NCT03662633
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 2300 (ESTIMATED)
- **Last updated:** 2022-10-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03662633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03662633, "Diagnosis Value of SEMA4C in Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03662633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*